Vogt-Koyanagi-Harada disease.

Vogt-Koyanagi-Harada disease is a chronic, granulomatous systemic autoimmune disease with manifestations in the ocular, central nervous, auditory, and integumentary systems. The target of attack seems to be antigens associated with melanocytes. Patients are usually of Asian, Middle Eastern, Asian Indian, Native American, or Hispanic ethnicity, and complain of neurologic symptoms quickly followed by decreased vision caused by a choroiditis, frequently with exudative retinal detachments. Corticosteroids are the mainstay of therapy, but other immunosuppressive therapy may be required. Complications, including cataract, glaucoma, choroidal neovascular membrane formation, and subretinal fibrosis, may limit final visual acuity.

[1]  E. Cunningham,et al.  Vogt-Koyanagi-Harada syndrome in a 4-year old child. , 1995, American journal of ophthalmology.

[2]  H. Inomata,et al.  Vogt-Koyanagi-Harada Syndrome , 1995, Survey of ophthalmology.

[3]  R. Nussenblatt,et al.  Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. , 1983, American journal of ophthalmology.

[4]  S. Lightman,et al.  Immunopathology of the noninfectious posterior and intermediate uveitides. , 2001, Survey of ophthalmology.

[5]  R. E. Smith,et al.  Complications and prognostic factors in Vogt-Koyanagi-Harada disease. , 2001, American journal of ophthalmology.

[6]  K. Norose,et al.  Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada disease. , 1990, Investigative ophthalmology & visual science.

[7]  S. Ng,et al.  Vogt-Koyanagi-Harada Disease: Extensive Vitiligo with Prodromal Generalized Erythroderma , 1999, Dermatology.

[8]  O. B. Evans,et al.  Vogt-Koyanagi-Harada syndrome in a 4-year-old child. , 1995, Pediatric neurology.

[9]  H. Goto,et al.  Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome. , 1990, International ophthalmology clinics.

[10]  H. Inoko,et al.  Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease. , 1994, Human immunology.

[11]  S. D. McPherson,et al.  Harada's disease. , 1949, American journal of ophthalmology.

[12]  S. Ohno,et al.  Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. , 1990, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[13]  N. Rao,et al.  Echographic features of the Vogt-Koyanagi-Harada syndrome. , 1990, Archives of ophthalmology.

[14]  Y. Jiang,et al.  Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. , 1991, Archives of ophthalmology.

[15]  M. Ishii,et al.  Inflammatory vitiligo in Vogt-Koyanagi-Harada disease. , 2001, Journal of the American Academy of Dermatology.

[16]  S. Sugiura [Some observations on uveitis in Japan, with special reference to Vogt-Koyanagi-Harada and Behçet diseases (author's transl)]. , 1976, Nippon Ganka Gakkai zasshi.

[17]  A. Kamondi,et al.  Vogt–Koyanagi–Harada disease presenting initially as aseptic meningoencephalitis , 2000, European journal of neurology.

[18]  K. Yamaki,et al.  Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. , 2000, Experimental eye research.

[19]  J. Kalil,et al.  HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. , 1998, Human immunology.

[20]  N. Rao Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome , 1997, Eye.

[21]  S. Ohno,et al.  Clinical studies of Vogt-Koyanagi-Harada's disease. , 1988, Japanese journal of ophthalmology.

[22]  E. Cunningham,et al.  Vogt-Koyanagi-Harada syndrome in children. , 1998, Ocular immunology and inflammation.

[23]  Hiroya Kobayashi,et al.  Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient , 1998, Immunogenetics.

[24]  R. Nussenblatt,et al.  HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. , 1990, Ophthalmology.

[25]  H. Inomata,et al.  Class II major histocompatibility complex on melanocytes of Vogt-Koyanagi-Harada disease. , 1991, Archives of ophthalmology.

[26]  I. Nagano,et al.  Melanin-laden macrophages in cerebrospinal fluid in Vogt-Koyanagi-Harada syndrome. , 1996, Archives of ophthalmology.

[27]  H. Inomata,et al.  Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease. , 2001, American journal of ophthalmology.

[28]  R. E. Smith,et al.  Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome. , 1994, American journal of ophthalmology.

[29]  J. Forrester,et al.  Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis. , 1998, Archives of ophthalmology.

[30]  E. Pattison UVEOMENINGOENCEPHALITIC SYNDROME (VOGT-KOYANAGI-HARADA). , 1965, Archives of neurology.

[31]  Y. Wakatsuki,et al.  Combination therapy with cyclosporin A and steroid in severe case of Vogt-Koyanagi-Harada's disease. , 1988, Japanese journal of ophthalmology.

[32]  S. Ohno,et al.  FK506 treatment of noninfectious uveitis. , 1994, American journal of ophthalmology.

[33]  D. Wakefield,et al.  Cyclosporine: a therapy in inflammatory eye disease. , 1991, Journal of ocular pharmacology.

[34]  M. Goldgeier,et al.  The distribution of melanocytes in the leptomeninges of the human brain. , 1984, The Journal of investigative dermatology.

[35]  E. Cunningham,et al.  Vogt-Koyanagi-Harada syndrome after cutaneous injury. , 1999, Ophthalmology.

[36]  D. Char,et al.  Vogt-Koyanagi-Harada syndrome. , 1977, American journal of ophthalmology.

[37]  T. Osato,et al.  [High inducibility of Epstein-Barr virus replication in B lymphocytes in Vogt-Koyanagi-Harada disease]. , 1999, Nippon Ganka Gakkai zasshi.

[38]  D. A. Snyder,et al.  Vogt-Koyanagi-Harada syndrome. , 1980, American journal of ophthalmology.

[39]  A. Burguet,et al.  HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients. , 1998, Ocular immunology and inflammation.

[40]  A. Urayama,et al.  A nationwide survey on the occurrence of Vogt-Koyanagi-Harada disease in Japan. , 1994, Japanese journal of ophthalmology.

[41]  Pan Qifeng,et al.  Old World sources of the first New World human inhabitants: A comparative craniofacial view , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Rubsamen,et al.  Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. , 1991, Archives of ophthalmology.

[43]  M. Varney,et al.  Vogt-Koyanagi-Harada syndrome in patients of Vietnamese ancestry. , 1996, Australian and New Zealand journal of ophthalmology.

[44]  C. Foster,et al.  Immunosuppressive drugs in immune and inflammatory ocular disease. , 1991, Survey of ophthalmology.

[45]  T. Gohdo,et al.  Ultrasound Biomicroscopy of shallow anterior chamber in Vogt-Koyanagi-Harada syndrome. , 1996, American journal of ophthalmology.

[46]  W. Freeman,et al.  Vogt-Koyanagi-Harada syndrome in children compared to adults. , 1998, Acta ophthalmologica Scandinavica.

[47]  M. Accorinti,et al.  Vogt-Koyanagi-Harada disease and HLA type in Italian patients. , 1996, American journal of ophthalmology.

[48]  T. G. Kim,et al.  Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. , 2000, American journal of ophthalmology.

[49]  P. Terasaki,et al.  Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California. , 1995, Ophthalmology.

[50]  N. Nao-i,et al.  Ultrasound biomicroscopic findings of acute angle-closure glaucoma in Vogt-Koyanagi-Harada syndrome. , 1996, American journal of ophthalmology.

[51]  H. Inomata,et al.  Ultrasound biomicroscopic analysis of transient shallow anterior chamber in Vogt-Koyanagi-Harada syndrome. , 1996, American journal of ophthalmology.

[52]  R. E. Smith,et al.  Subretinal neovascular membranes in Vogt-Koyanagi-Harada syndrome. , 1993, American journal of ophthalmology.

[53]  G. Peyman,et al.  Detection of Epstein-Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-Koyanagi-Harada syndrome. , 1996, Retina.

[54]  G. Baerveldt,et al.  Incidence and management of glaucoma in Vogt-Koyanagi-Harada syndrome. , 1993, Ophthalmology.

[55]  C. Flaxel,et al.  The use of corticosteroids for choroidal neovascularisation in young patients , 1998, Eye.

[56]  S. Ohno,et al.  Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. , 2001, American journal of ophthalmology.

[57]  H. Inomata,et al.  Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site , 1996, Graefe's Archive for Clinical and Experimental Ophthalmology.

[58]  A. Dick,et al.  Cyclosporine-induced resolution of choroidal neovascularization associated with sympathetic ophthalmia. , 1998, Archives of ophthalmology.